XML 21 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Revenues $ 40,994 $ 6,102 $ 110,012 $ 13,796
Expenses        
Cost of product sales 591 1,517 6,811 1,517
Research and development 49,971 30,245 145,279 87,610
Selling, general and administrative 34,992 17,195 83,431 46,943
Royalty 24 9 34 78
Total operating expenses 85,578 48,966 235,555 136,148
Loss from operations (44,584) (42,864) (125,543) (122,352)
Interest and other income (expense) 9 (312) 48 8,892
Interest expense (14,115) (2,927) (40,514) (8,892)
(Loss) gain on foreign currency (111) (12) (274) 31
Net loss (58,801) (46,115) (166,283) (122,321)
Foreign currency translation adjustment 28 0 114 0
Unrealized gain (loss) on available for sale investments (1) 6 (3) (30)
Comprehensive loss $ (58,774) $ (46,109) $ (166,172) $ (122,351)
Basic and diluted net loss per common share (in dollars per share) $ (330) $ (260) $ (930) $ (750)
Weighted average shares outstanding (in shares) 179,106 176,521 178,199 164,127
Product [Member]        
Revenues:        
Revenues $ 39,141 $ 2,478 $ 90,442 $ 2,696
Royalty [Member]        
Revenues:        
Revenues 322 254 (447) 2,243
Milestone [Member]        
Revenues:        
Revenues 0 0 15,000 0
Collaborative and Other Research and Development [Member]        
Revenues:        
Revenues $ 1,531 $ 3,370 $ 5,017 $ 8,857